The Parsippany-based Medicines Co. announced Monday an underwritten public offering of up to 5.5 million shares of its common stock.
J.P. Morgan Securities LLC and Bank of America Merrill Lynch are acting as joint book-running managers, and representatives of the underwriters for the offering. Leerink Swann LLC also is acting as a joint book-running manager.
Medicines Co. intends to grant the underwriters a 30-day option to purchase up to an additional 825,000 shares of its common stock. The offering is subject to market conditions that may delay or prevent the offering from being completed, or impact the actual size or terms of the offering.
Digital content editor Joe Ross is @joeross on Twitter.